Trial record 1 of 579 for:
RS Oncology
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05278975 |
|
Recruitment Status :
Recruiting
First Posted : March 15, 2022
Last Update Posted : January 26, 2024
|
Sponsor:
RS Oncology LLC
Information provided by (Responsible Party):
RS Oncology LLC
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | April 1, 2025 |
| Estimated Study Completion Date : | April 1, 2025 |